Loading...

Choosing Phase II Endpoints and Designs: Evaluating the possibilities

Selecting the Phase II design and endpoint to achieve the best possible chance of success for a confirmatory Phase III study in a particular disease and treatment setting is challenging but critical. Simulating from existing clinical trial data sets, and mathematical models, can be useful tools for...

Full description

Saved in:
Bibliographic Details
Published in:Clin Cancer Res
Main Authors: LeBlanc, Michael, Tangen, Catherine
Format: Artigo
Language:Inglês
Published: 2012
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4820349/
https://ncbi.nlm.nih.gov/pubmed/22407830
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-0454
Tags: Add Tag
No Tags, Be the first to tag this record!